Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lauren Herschelman"'
Autor:
Edward M. Kennedy, Agnieszka Denslow, Jacqueline Hewett, Lingxin Kong, Ana De Almeida, Jeffrey D. Bryant, Jennifer S. Lee, Judy Jacques, Sonia Feau, Melissa Hayes, Elizabeth L. McMichael, Daniel Wambua, Terry Farkaly, Amal A Rahmeh, Lauren Herschelman, Danielle Douglas, Jacob Spinale, Sanmit Adhikari, Jessica Deterling, Matt Scott, Brian B. Haines, Mitchell H. Finer, Ted T Ashburn, Christophe Quéva, Lorena Lerner
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)
The development of neutralizing antibodies can limit the therapeutic effectiveness of systemically administered oncolytic viruses (OV). Here, to enable repeated intravenous administration, the authors report the development of synthetic RNA viruses f
Externí odkaz:
https://doaj.org/article/e35ea397d9ba41b5b30d0dfa85eb8713
Autor:
Ana De Almeida, Judy Jacques, Jacqueline Hewett, Mitchel H. Finer, Amal Rahmeh, Edward M. Kennedy, Lorena Lerner, Jennifer Lee, Danielle Douglas, Brian B. Haines, Lauren Herschelman, Sonia Feau, Lingxin Kong, Matt Scott, Melissa Hayes, Christophe Quéva, Sanmit Adhikari, Jessica Deterling, Jacob Spinale, Jeffrey Bryant, Agnieszka Denslow, Elizabeth McMichael, Ted Ashburn
Oncolytic viruses (OVs) are an emerging therapeutic approach for the treatment of cancer. Clinical benefit has been demonstrated for intratumoral administration, but the therapeutic effectiveness of intravenous delivery has been limited by neutralizi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69f2c6ae8f6099221e993d23ed04163e
https://doi.org/10.21203/rs.3.rs-523458/v1
https://doi.org/10.21203/rs.3.rs-523458/v1